Results 131 to 140 of about 3,663 (172)

Alirocumab

Practical Diabetes, 2016
openaire   +1 more source

Alirocumab and Lipid Levels, Inflammatory Biomarkers, Metabolomics, and Safety in Patients Receiving Maintenance Dialysis: The ALIrocumab in DIALysis Study (A Phase 3 Trial to Evaluate the Efficacy and Safety of Biweekly Alirocumab in Patients on a Stable Dialysis Regimen)

Kidney Medicine, 2022
Ankit Mehta, Sandy Zurawski, Teodoro Bottiglieri   +2 more
exaly  

Indirect comparison of the efficacy and safety of alirocumab and evolocumab: a systematic review and network meta-analysis

European Heart Journal - Cardiovascular Pharmacotherapy, 2020
Paul Guédeney, Sabato Sorrentino, Gennaro Giustino   +2 more
exaly  

Alirocumab/atorvastatin

Reactions Weekly, 2021
openaire   +1 more source

Alirocumab/evolocumab

Reactions Weekly, 2018
  +4 more sources

Alirocumab/prednisone

Reactions Weekly, 2022
openaire   +1 more source

Effect of Alirocumab on Lipoprotein(a) and Cardiovascular Risk After Acute Coronary Syndrome

Journal of the American College of Cardiology, 2020
Michael Szarek, Philip E Aylward, Rafael Diaz   +2 more
exaly  

Alirocumab-Induced Hyperlipasemia and Hyperamylasemia

Annals of Pharmacotherapy, 2020
Amer A. Alkhatib, Pascale Anglade
openaire   +2 more sources

Alirocumab

Drugs of the Future, 2013
openaire   +1 more source

Alirocumab/evolocumab

Reactions Weekly, 2021
openaire   +1 more source